相关实验视频

Updated: Jun 28, 2025

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

通过生物信息学和实验验证来解开关键m6A修改监管机构在绝经后骨质疏松症中的签名

Zhi-Wei Feng^1,2,3,4, He-Fang Xiao^1,3,4, Xing-Wen Wang^1,3,4

¹Department of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, China.

Orthopaedic surgery

|April 24, 2024

概括

在骨质疏松症中,YTH N6-甲基氨酸RNA结合蛋白3 (YTHDF3) 的含量降低,损害骨髓中酶干细胞的功能. 恢复YTHDF3可能会增强骨质疏松症患者的骨质形成.

科学领域:

生物医学科学生物医学科学
分子生物学分子生物学
干细胞研究干细胞研究

背景情况:

骨髓介质干细胞 (BMSCs) 对于骨形成至关重要.
骨质疏松症涉及到BMSCs的骨质基因分化受损.
调节骨质疏松性BMSCs (OP-BMSCs) 骨质疏松性能力的分子机制尚未完全理解.

研究的目的:

研究YTH N6-甲基氨酸RNA结合蛋白3 (YTHDF3) 在OP-BMSC中的作用.
确定YTHDF3作为增强骨质疏松症骨形成的潜在治疗点.

主要方法:

对基因表达综合 (GEO) 微阵列数据集 (GSE35956,GSE35958) 的分析,以确定骨质疏松症中的m6A调节者.
差异表达,蛋白质与蛋白质相互作用和机器学习分析以确定关键基因.
单细胞分析,免疫透评估,孟德尔随机化,体内实验和体外实验来验证发现.

主要成果:

YTHDF3被确定为与骨质疏松症相关的关键枢纽基因.
在骨质疏松症患者和小鼠模型中,YTHDF3的表达显著下降.
在OP-BMSC中杀YTHDF3抑制了扩散和骨质分化.

结论:

YTHDF3在骨质疏松症的发病过程中发挥着重要作用.
YTHDF3调节了OP-BMSCs的增殖和骨质分化.
向YTHDF3可能为骨质疏松症提供治疗策略.

关键词:

这就是BMSCs.骨质变异的分化骨质变异的分化绝经后的骨质疏松症绝经后的骨质疏松症核武器的扩散这就是YTHDF3的原因.

更多相关视频

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

相关概念视频

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...